Production of Oral IgY Antibody A Novel Immunotherapy against Clostridium Difficile

Abstract

Clostridium difficile is the leading cause of nosocomial infectious Antibiotic – Associated Diarrhea AAD . Like most other enteric bacterial pathogens, Clostridium difficile causes disease with a wide spectrum of severity ranging from mild‘nuisance’ diarrhea with a normal colonic mucosa to pseudo membranous colitis, which is characterized by severe abdominal pain, diarrhoea and fever. Constitutional signs such as fever, fatigue and loss of appetite are prominent. The incidence of infection with this organism is increased in hospitals worldwide, due to the use of broad spectrum antibiotics. Clostridium difficile is transmitted from person to person by the fecal oral route. However, the organism forms large numbers of heat resistant spores which remain viable in the hospital or nursing home environment for long periods of time. Infection rates for Clostridium difficile are reported to be around 10 after 2 weeks of hospitalization but may reach 50 after 4 or more weeks. Each year in North America, 1–3 of hospitalized patients receiving antibiotics become infected with C. difficile, leading to thousands of deaths and over 1 billion in associated costs to the health care system. Dr. R. Mahenthiran | Sornambiga Ravi | Sri Alamelu. K. V "Production of Oral IgY Antibody- A Novel Immunotherapy against Clostridium Difficile" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, URL: https://www.ijtsrd.com/papers/ijtsrd39892.pdf Paper URL: https://www.ijtsrd.com/biological-science/microbiology/39892/production-of-oral-igy-antibody-a-novel-immunotherapy-against-clostridium-difficile/dr-r-mahenthiran

Authors and Affiliations

Dr. R. Mahenthiran | Sornambiga Ravi | Sri Alamelu. K. V

Keywords

Related Articles

Method Development and Validation for Simultaneous Estimation of Dasatinib and Erlotinib by Using RP HPLC in Pharmaceutical Dosage Form

The present study describes a newly developed, optimized and validated isocratic RP HPLC method for the separation of two tyrosine kinase inhibitors Dasatinib DST and Erlotinib ERT with Methyl paraben MPB as internal sta...

Fixed Output DC to DC Converter for Photovoltaic System

In This Paper, The Variable Input Voltage And Fixed Output Voltage DC To DC Converter For Photovoltaic System PV System Is Designed, Simulated And Constructed. There Are Three Main Portions In The Proposed System. They A...

Study on the Effect of Response Spectrum Analysis and Construction Sequence Analysis on Setback Steel Structure

This paper presents the effect of response spectrum analysis and construction sequence analysis on the setback steel structure. In this study, the proposed building is eleven storey setback steel structure. The length of...

Military Radar System

This paper describes about military radar system is going now a days and in future development of the system. How‘s the military operation performed by the radar system. the basically three type of radar are in the rad...

4 G Wave of Mobile Services in India

Telecommunication industry is one of the most rising industry which evolved at faster rate in last 10 15 years. Recently, India is the world’s second largest telecommunication market and still growing. Mobile economy i...

Download PDF file
  • EP ID EP695248
  • DOI -
  • Views 69
  • Downloads 0

How To Cite

Dr. R. Mahenthiran, Sornambiga Ravi (2021). Production of Oral IgY Antibody A Novel Immunotherapy against Clostridium Difficile. International Journal of Trend in Scientific Research and Development, 5(3), -. https://europub.co.uk/articles/-A-695248